Archie Bleyer, MD
Clinical Research Professor, Radiation Medicine
Archie Bleyer, MD, is Senior Advisor and Health Services Research Collaborator, Cancer Medicine, Knight Cancer Institute, OHSU and Collaborator, Institute of Health Metrics and Evaluation, University of Washington .
Dr. Bleyer chaired the Children’s Cancer Group for 10 years, then the world's largest pediatric cancer research organization, the Department and Division of Pediatrics at the University of Texas MD Anderson Cancer Center, and Community Oncology in the Department and Division of Medicine at the M.D. Anderson Cancer Center. He was the American Cancer Society Professor of Clinical Oncology and in charge of the cancer curriculum in the University of Washington School of Medicine.
During the past four decades, Dr. Bleyer was awarded research grants totaling more than $ 87 million as a principal investigator from the National Institutes of Health, the American Cancer Society, University of Texas and the Leukemia Society of America. He is an author on more than 300 peer-reviewed articles, 77 book chapters, and 10 books, and the senior editor of the Cancer in Adolescents and Young Adults book. His current personal clinical research is dedicated to adolescents and young adult (AYA) oncology and to social science issues (suicide, firearm deaths, substance abuse) in young Americans.
Undergraduate:
Medical Education:
University of Rochester, School of Medicine and Dentistry
Residency Training:
Pediatric Medicine, University of Washington, School of Medicine
Fellowship:
University of Washington, School of Medicine
Journal of Clinical Pathways. 7 Aug 2019 The Growth of Pediatric Oncology and Optimal Care for Pediatric Acute Lymphoblastic Leukemia
Pediatr Blood Cancer. 2018 Jul;65(7):e27013. doi: 10.1002/pbc.27013. Epub 2018 Mar 1. The challenge of the management of adolescents and young adults with soft tissue sarcomas. Ferrari A, Bleyer A, Patel S, Chiaravalli S, Gasparini P, Casanova M. https://www.ncbi.nlm.nih.gov/pubmed/29493075
Pediatr Blood Cancer. 2018 Aug;65(8):e27025. doi: 10.1002/pbc.27025. Epub 2018 Mar 12. Thyroid cancer in adolescents and young adults. Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A. https://www.ncbi.nlm.nih.gov/pubmed/29528191
Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection – a review. Beaupin L, Bostrom B, Barth M, Jaeger R, Kamath P, Schreiber B, Bleyer A. Pages 766-772 | Received 01 Feb 2016, Accepted 24 Jul 2016, Published online: 19 Sep 2016
Future Oncology VOL. 13, NO. 14 | Special Report. Thyroid cancer in adolescents and young adults. 15 Jun 2017 Doi: https://doi.org/10.2217/fon-2017-0024
Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance. Ramsey LB, Balis FM, O'Brien MM, Schmiegelow K, Pauley JL, Bleyer A, Widemann BC, Askenazi D, Bergeron S, Shirali A,Schwartz S, Vinks AA, Heldrup J.
Could the Rising Rates of Colorectal Cancer in AYAs Be Linked to HPV Infection?
Into the Age of Miracles & the Greatest Story Ever Told
Generalizability of SWOG Treatment Trial Results
Dr. Bleyer is sr. author on major SEER database update on breast cancer incidence patters
Dr. Bleyer is co-author of a population-based research analysis
New York Time: "In Cancer Fight, Teenagers Don't Fit In"
Relative Lack of Conditional Survival Improvement in Young Adults With Cancer